University of Freiburg-ko ikertzaileekin lankidetzan egindako argitalpenak (31)

2023

  1. Survival advantage of treosulfan plus fludarabine (FT14) compared to busulfan plus fludarabine (FB4) in active acute myeloid leukemia post allogeneic transplantation: an analysis from the European Society for Blood and Marrow Transplantation (EBMT) Acute Leukemia Working Party (ALWP)

    Bone Marrow Transplantation, Vol. 58, Núm. 10, pp. 1084-1088

2022

  1. Allogeneic hematopoietic stem cell transplantation for adult HLH: a retrospective study by the chronic malignancies and inborn errors working parties of EBMT

    Bone Marrow Transplantation, Vol. 57, Núm. 5, pp. 817-823

  2. Effect of Combination Antibiotic Empirical Therapy on Mortality in Neutropenic Cancer Patients with Pseudomonas aeruginosa Pneumonia

    Microorganisms, Vol. 10, Núm. 4

  3. Pseudomonas aeruginosa Bloodstream Infections in Patients with Cancer: Differences between Patients with Hematological Malignancies and Solid Tumors

    Pathogens, Vol. 11, Núm. 10

2021

  1. Characteristics of adult patients with chronic intestinal failure due to short bowel syndrome: An international multicenter survey

    Clinical Nutrition ESPEN, Vol. 45, pp. 433-441

  2. Comparing outcomes of a second allogeneic hematopoietic cell transplant using HLA-matched unrelated versus T-cell replete haploidentical donors in relapsed acute lymphoblastic leukemia: a study of the Acute Leukemia Working Party of EBMT

    Bone Marrow Transplantation, Vol. 56, Núm. 9, pp. 2194-2202

  3. Phenotype and risk factors of venom-induced anaphylaxis: A case-control study of the European Anaphylaxis Registry

    Journal of Allergy and Clinical Immunology, Vol. 147, Núm. 2, pp. 653-662.e9

2020

  1. Clinical features associated with COVID-19 outcome in multiple myeloma: First results from the International Myeloma Society data set

    Blood, Vol. 136, Núm. 26, pp. 3033-3040

  2. Clinical predictive model of multidrug resistance in neutropenic cancer patients with bloodstream infection due to Pseudomonas aeruginosa

    Antimicrobial Agents and Chemotherapy, Vol. 64, Núm. 4

  3. Secondary prevention measures in anaphylaxis patients: Data from the anaphylaxis registry

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 75, Núm. 4, pp. 901-910

2019

  1. Impact of antibiotic resistance on outcomes of neutropenic cancer patients with Pseudomonas aeruginosa bacteraemia (IRONIC study): Study protocol of a retrospective multicentre international study

    BMJ Open, Vol. 9, Núm. 5

2018

  1. Clinical approach to the management of Intestinal Failure Associated Liver Disease (IFALD) in adults: A position paper from the Home Artificial Nutrition and Chronic Intestinal Failure Special Interest Group of ESPEN

    Clinical Nutrition, Vol. 37, Núm. 6, pp. 1794-1797

  2. Clinical classification of adult patients with chronic intestinal failure due to benign disease: An international multicenter cross-sectional survey

    Clinical Nutrition, Vol. 37, Núm. 2, pp. 728-738

  3. EAACI guidelines on allergen immunotherapy: Hymenoptera venom allergy

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 73, Núm. 4, pp. 744-764

  4. Optimised care of elderly patients with acute coronary syndrome

    European heart journal. Acute cardiovascular care, Vol. 7, Núm. 3, pp. 287-295

2017

  1. Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial

    The Lancet, Vol. 389, Núm. 10081, pp. 1799-1808

  2. Corrigendum to “ESPEN guidelines on chronic intestinal failure in adults” [Clin Nutr 35 (2) (2016) 247–307] (S0261561416000479) (10.1016/j.clnu.2016.01.020)

    Clinical Nutrition

  3. Long-term survival of patients with CLL after allogeneic transplantation: A report from the European Society for Blood and Marrow Transplantation

    Bone Marrow Transplantation, Vol. 52, Núm. 3, pp. 372-380

  4. Platelet Inhibition as a Therapeutic Approach in Intravascular Intervention

    PLATELETS, HAEMOSTASIS AND INFLAMMATION (SPRINGER INTERNATIONAL PUBLISHING AG), pp. 99-109

  5. The carbapenemase-producing Klebsiella pneumoniae population is distinct and more clonal than the carbapenem-susceptible population

    Antimicrobial Agents and Chemotherapy, Vol. 61, Núm. 4